Home › NDC Lookup › RxCUI directory › RxCUI 2635020

Ivacaftor 59.5 MG Oral Granules — RxCUI 2635020

RxNorm drug concept · Semantic clinical drug
RxCUI 2635020 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2635020
Official nameIvacaftor 59.5 MG Oral Granules
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)51,835 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ivacaftor: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Kalydeco doesn't cure cystic fibrosis, but it targets the root cause in people with certain gene mutations. It helps a faulty protein in your cells — called CFTR — work better by k...
  • What exactly does Kalydeco do for cystic fibrosis — does it cure it?
  • It really does matter what you take it with. Fat in food increases how much ivacaftor your body absorbs — by as much as 2.5 to 4 times. Taking it with just water means you're likel...
  • Why does it have to be taken with food? Can I just take it with water?
📖 Read our full Ivacaftor guide →

🕸️ Concept Web — How Ivacaftor 59.5 MG Oral Granules Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ivacaftor 59.5 MG Oral Granules RxCUI 2635020

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ivacaftor 1243041
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ivacaftor Oral Granules 1606861
    • Ivacaftor Granule Product 1606860
    • Ivacaftor Oral Product 1243043
    • Oral Granules 317690
    • Granule Product 1294708
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ivacaftor 59.5 MG 2635014
  4. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2635020 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51167-0106-02 4 BLISTER PACK in 1 CARTON (51167-106-02) / 1 KIT in 1 BLIS... Trikafta Vertex Pharmaceuticals Incorporated 2021-06-08
51167-0331-01 4 BLISTER PACK in 1 CARTON (51167-331-01) / 1 KIT in 1 BLIS... Trikafta Vertex Pharmaceuticals Incorporated 2019-10-21
51167-0445-01 4 PACKAGE in 1 CARTON (51167-445-01) / 1 KIT in 1 PACKAGE *... Trikafta Vertex Pharmaceuticals Incorporated 2023-04-26
51167-0446-01 4 PACKAGE in 1 CARTON (51167-446-01) / 1 KIT in 1 PACKAGE *... Trikafta Vertex Pharmaceuticals Incorporated 2023-04-26
Observed labelers: Vertex Pharmaceuticals Incorporated (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.